Rilonacept Regeneron: EPAR - Conditions imposed on member states for safe and effective use - Annex IV
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Source
European Medicines Agency
Additional Information
medication.label.product_type
conditions-member-states
medication.label.permit_validity
First published: 2009-11-12T01:00:00Z
Related Medications
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
AI Voice
Listen to the article content live